Table 5 Change in symptom severity and impairment score for depression, epilepsy and psychosis patients at PRIME implementation clinics in Kamuli District, Uganda, 2015–2017
Disorder | Measurement | Baseline score | Midlinea score | Endline score | Midlinea difference in score vs. baseline (95% CI) | Endline difference in score vs. baseline (95% CI) |
|---|---|---|---|---|---|---|
Outcome | ||||||
Depression | ||||||
 Symptom severity | Mean PHQ-9 (SD) | 16.3 (4.6) | 8.4* (6.3) | 6.4* (5.6) | − 7.9 (− 12.6, − 3.2) | − 9.9 (− 14.4, − 5.4) |
 Impairment | Mean WHODAS (SD) | 48.4 (18.0) | 26.7* (22.1) | 22.6* (22.3) | − 21.7 (− 35.4, − 7.9) | − 25.8 (− 39.2, − 12.4) |
Psychosis | ||||||
 Impairment | Mean WHODAS (SD) | 34.9 (27.2) | 14.2* (18.8) | 15.7* (20.9) | − 20.7 (− 31.3, − 10.1) | − 19.2 (− 30.1, − 8.4) |
Epilepsy | ||||||
 Symptom severity | Median # seizures in past 30 days (IQR) | 3 (1–5) | 1** (0–4) | 2** (0–4) |  |  |
 Impairment | Mean WHODAS (SD) | 35.9 (23.6) | 26.9* (29.0) | 23.5* (27.9) | − 9.1 (− 17.4, − 0.8) | − 12.4 (− 20.5, − 4.4) |